Mode
Text Size
Log in / Sign up

Pheochromocytoma

Part of Germ cell tumors

6 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for pheochromocytoma

7 trials tracked for pheochromocytoma: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 183 citations.

7Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 6
  1. Phase 3 Preoperative Alpha Blockade for Pheochromocytoma Completed · 183 cited
  2. Phase 2 Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study Completed
  3. Phase 2 Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma Completed
  4. Phase 2 A Phase II Study of 131I- Metaiodobenzylguanidine (MIBG) for Treatment of Metastatic or Unresectable Pheochromocytoma and Related Tumors Completed
  5. Phase 2 A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... Completed
  6. Phase 2 Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma Completed
Show 1 more trials
  1. Phase 2 Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about pheochromocytoma

Do people with SDHD mutations often develop multiple pheochromocytoma tumors?

People with SDHD mutations are frequently associated with multifocal tumors, which can include multiple pheochromocytoma or paraganglioma sites.

Full answer →
Can deep learning and radiomics help identify a pheochromocytoma in adrenal masses?

Deep learning and radiomics are promising tools that can help doctors distinguish pheochromocytoma from other types of adrenal masses using medical imaging.

Full answer →